Cardiol Therapeutics (CRDL) News Today C$1.80 -0.06 (-3.23%) As of 07/11/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock CRDL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Cardiol Therapeutics (TSE:CRDL) Trading Up 1% - Here's WhyJuly 5, 2025 | marketbeat.comCardiol Therapeutics Inc. (CRDL.TO) - Yahoo FinanceJune 26, 2025 | finance.yahoo.comCardiol Therapeutics (TSE:CRDL) Trading Up 2.1% - Here's What HappenedJune 13, 2025 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Stock Price Down 5.2% - Time to Sell?May 24, 2025 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Trading Up 6.7% - What's Next?May 2, 2025 | marketbeat.comStocks in play: ardiol Therapeutics Inc.April 17, 2025 | ca.finance.yahoo.comCardiol Therapeutics (TSE:CRDL) Reaches New 1-Year Low - Should You Sell?April 9, 2025 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Hits New 12-Month Low - Here's What HappenedApril 3, 2025 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Reaches New 12-Month Low - What's Next?March 27, 2025 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Stock Price Down 5% - Time to Sell?March 26, 2025 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Sets New 52-Week Low - Time to Sell?March 5, 2025 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Sets New 1-Year Low - Time to Sell?February 24, 2025 | marketbeat.comCardiol Therapeutics reports heart failure treatment progressFebruary 21, 2025 | investing.comCardiol Therapeutics (TSE:CRDL) Hits New 52-Week Low - Here's WhyFebruary 15, 2025 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Trading Down 7.7% - Time to Sell?February 8, 2025 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Shares Down 3.4% - Here's What HappenedJanuary 17, 2025 | marketbeat.comInsider Buying: Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Acquires 17,240 Shares of StockDecember 27, 2024 | insidertrades.comCardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Guillermo Torre Buys 17,240 SharesDecember 26, 2024 | marketbeat.comAndrew Warwick Hamer Purchases 18,900 Shares of Cardiol Therapeutics Inc. (TSE:CRDL) StockDecember 25, 2024 | insidertrades.comInsider Buying: Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Purchases 18,900 Shares of StockDecember 24, 2024 | marketbeat.comVernon Bernardino Issues Buy Rating on Cardiol Therapeutics Following Promising Clinical Results and Strong Financial PositionDecember 19, 2024 | markets.businessinsider.comInsider Buying: Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Purchases 10,000 Shares of StockDecember 17, 2024 | marketbeat.comDavid Elsley Buys 40,000 Shares of Cardiol Therapeutics Inc. (TSE:CRDL) StockDecember 17, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Trading Down 2.1% - Here's What HappenedDecember 14, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Stock Price Up 1.8% - Here's What HappenedNovember 22, 2024 | marketbeat.comCBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical StudyNovember 19, 2024 | benzinga.comCardiol Therapeutics added to PRISM Emerging Biotech IndexNovember 13, 2024 | markets.businessinsider.comCardiol Therapeutics (TSE:CRDL) Shares Down 0.8% - Should You Sell?October 31, 2024 | marketbeat.comCardiol Therapeutics Expands Trials for Heart TreatmentOctober 22, 2024 | markets.businessinsider.comWhy Cardiol Therapeutics (CRDL) Stock Is Down 20% TodayOctober 9, 2024 | benzinga.comCardiol Therapeutics (TSE:CRDL) Trading Down 19.7% - Here's What HappenedOctober 9, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Trading Up 1.1%September 27, 2024 | marketbeat.comCardiol Therapeutics to present Phase II study resultsSeptember 12, 2024 | uk.investing.comCardiol Therapeutics (TSE:CRDL) Stock Price Up 0.8%September 5, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Stock Price Up 3.6%August 14, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Stock Price Up 1.6%July 23, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Trading Down 0.7%July 16, 2024 | marketbeat.comDavid Elsley Acquires 50,000 Shares of Cardiol Therapeutics Inc. (TSE:CRDL) StockJune 25, 2024 | insidertrades.comInsider Buying: Cardiol Therapeutics Inc. (TSE:CRDL) Director Purchases 50,000 Shares of StockJune 24, 2024 | marketbeat.comCardiol Therapeutics (TSE:CRDL) Shares Up 11.7%June 10, 2024 | marketbeat.comAnalysts Conflicted on These Healthcare Names: Cardiol Therapeutics (CRDL) and MicroPort Scientific (OtherMCRPF)May 14, 2024 | markets.businessinsider.comManufacturing, Housing Due Next Week in CanadaMay 10, 2024 | baystreet.caCardiol Therapeutics (TSE:CRDL) Trading 12.9% Higher April 30, 2024 | marketbeat.comBuy Rating on Cardiol Therapeutics: Projected Blockbuster CardiolRx’s Strategic Advantages and Market PotentialApril 23, 2024 | markets.businessinsider.comClosing Bell: Cardiol Therapeutics Inc Purchase WT up on Tuesday (CRDL-WT-A)April 20, 2024 | theglobeandmail.comCRDL:CA Cardiol Therapeutics Inc.April 13, 2024 | seekingalpha.comCardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent PericarditisFebruary 21, 2024 | finance.yahoo.comClosing Bell: Cardiol Therapeutics Inc Purchase WT down on Monday (CRDL-WT-A)February 9, 2024 | theglobeandmail.comIs Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?February 2, 2024 | finance.yahoo.comCardiol Therapeutics Inc Class AJanuary 30, 2024 | morningstar.comM Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address CRDL Media Mentions By Week CRDL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRDL News Sentiment▼0.001.01▲Average Medical News Sentiment CRDL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRDL Articles This Week▼00▲CRDL Articles Average Week Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Tilray Brands News Aimia News Fennec Pharmaceuticals News International Tower Hill Mines News Andean Precious Metals News Gear Energy News Graphite One News EQ News Medicenna Therapeutics News CI Canadian Convertible Bond ETF Common News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CRDL) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredDid you miss out on Trump’s “birthday gift” to Americans?While protestors were rallying against “King Trump,” one trader quietly spotted a 15% weekend move tied to his...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
